MTOR and hepatocellular carcinoma: Building on our current understanding of mTOR's role in SASP production and the involvement of SASP in tumorigenesis, it would be reasonable to hypothesize that mTOR inhibition could be used as chemoprophylaxis in CLD against the development of HCC.